Summary
Wells Fargo & Company/MN (WFC) filed its quarterly report for the period ending March 31, 2026, on April 29, 2026. The filing primarily details ongoing legal proceedings, risk factors, and equity repurchase activities. While comprehensive financial statements are not included in this excerpt, investors should note the company's continued repurchase of its common stock under a significant authorization, indicating a commitment to shareholder returns. The report also confirms no new trading plans were adopted or terminated by directors or officers during the quarter, suggesting a stable insider trading policy environment.
Financial Highlights
33 data pointsBeta
Financial Statements
Beta
| Net Income | $5.25B |
| EPS (Basic) | $1.62 |
| EPS (Diluted) | $1.60 |
| Shares Outstanding (Basic) | 3.08B |
| Shares Outstanding (Diluted) | 3.12B |
Key Highlights
- 1The company repurchased a total of 46,306,204 shares of common stock during the quarter ended March 31, 2026.
- 2These repurchases were executed under an existing authorization of up to $40 billion approved on April 29, 2025.
- 3The weighted average price paid per share for repurchases ranged from $82.00 to $88.26 during the quarter.
- 4As of March 31, 2026, approximately $25.758 billion remained available under the share repurchase authorization.
- 5No directors or officers adopted or terminated Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements during the quarter.
- 6The report incorporates by reference detailed information on legal proceedings and risk factors into the relevant sections.
Frequently Asked Questions
The total approximate dollar value of shares repurchased during the quarter ended March 31, 2026, can be calculated by summing the weighted average price paid per share multiplied by the total number of shares repurchased each month. For instance, in January, 18,000,000 shares were repurchased at an average price of $88.26, resulting in approximately $1.589 billion in repurchases for that month.
As of March 31, 2026, approximately $25.758 billion of the $40 billion common stock repurchase authorization remains available. This authorization, approved on April 29, 2025, does not have an expiration date unless modified or revoked by the Board of Directors.
No, the report explicitly states that during the quarter ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 or non-Rule 10b5-1 trading arrangements.
Information regarding legal proceedings is incorporated by reference to Note 9 (Legal Actions) to the Financial Statements within the report. Risk factors are detailed in the “Financial Review – Risk Factors” section of the report, also incorporated by reference.